Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617

Added 152 days ago (24.12.2021)
Authors: Peng, L., Hu, Y., Mankowski, M., Ren, P., Chen, R., Wei, J., Zhao, M., Li, T., Tripler, T., Ye, L., Chow, R., Fang, Z., Wu, C., Dong, M., Cook, M., Wang, G., Clark, P., Nelson, B., Klein, D., Sutton, R., Diamond, M., Wilen, C., Xiong, Y., Chen, S.
Source: bioRxiv
Read article